CAR T-cell product performance in haematological malignancies before and after marketing authorisation.
Lancet Oncol. 2020 Feb;21(2):e104-e116. doi: 10.1016/S1470-2045(19)30729-6.
Lancet Oncol. 2020.
PMID: 32007196
Review.